• News
  • SAN DIEGO
  • Medical

Scripps Health awarded $3.75M grant from Qualcomm Foundation

Related Special Reports

Scripps Health announced Wednesday that it has been awarded a $3.75 million grant from the Qualcomm Foundation, to be used for the Scripps Translational Science Institute.

The funding will advance clinical trials of wireless biosensor systems, the creation of rapid pharmacogenomic diagnostic tests that can be administered in retail stores, and the development of apps and embedded sensors for tracking and predicting heart attacks, Type 1 diabetes and certain types of cancer.

"The combination of wireless technologies, sensors, diagnostics and DNA sequencing tools offers unparalleled opportunities to dramatically impact health care,” said Dr. Paul E. Jacobs, Qualcomm Inc.'s chairman and CEO and Qualcomm Foundation chair. “The Qualcomm Foundation is proud to support this endeavor – bringing breakthrough technologies to the field of medicine to improve patient care."

The Scripps Translational Science Institute was established by Scripps Health in collaboration with various parties to support the development of breakthrough digital technologies designed to revolutionize the practice of medicine.

The Qualcomm Foundation was established in 2010 by Qualcomm Inc. (Nasdaq: QCOM) to develop and strengthen communities worldwide through the philanthropic support of inspirational and innovative programs that serve diverse populations.

User Response
0 UserComments

Scripps Health

Company Website

9888 Genessee Ave.
La Jolla, CA 92037

Scripps Health Executive(s):

Chris Van Gorder

  • Chief Executive Officer, President

Victor Buzachero

  • Senior Vice President

Richard Rothberger

  • Chief Financial Officer, Executive VP

Arnold Eastman

  • Senior Vice President, Chief Medical Officer

Related Videos

Scripps Cardiovascular Institution breaks ground

June 21, 2011 - Scripps Health broke ground on a cardiovascular center in La Jolla that is expected to open in 2015. Reporter Carlos Rico has the details.